|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.01 INR | -1.27% |
|
-9.20% | -14.01% |
| Market Cap | 1.09B 11.42M 10.01M 9.24M 8.54M 16.19M 16.52M 111M 43.18M 535M 42.87M 41.93M 1.86B | P/E 2024 |
-12.2x | P/E 2025 | -28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 12.2M 10.7M 9.88M 9.13M 17.31M 17.66M 119M 46.16M 572M 45.83M 44.83M 1.99B | EV / Sales 2024 |
3.16x | EV / Sales 2025 | 3.93x |
| Free-Float |
43.99% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.27% | ||
| 1 week | -9.20% | ||
| Current month | +0.09% | ||
| 1 month | +1.11% | ||
| 3 months | -3.33% | ||
| 6 months | -7.16% | ||
| Current year | -14.01% |
| 1 week | 66.53 | 79 | |
| 1 month | 65 | 79 | |
| Current year | 36.9 | 82.3 | |
| 1 year | 36.9 | 165.95 | |
| 3 years | 36.9 | 202.8 | |
| 5 years | 36.9 | 202.8 | |
| 10 years | 14.05 | 202.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Rathi
CEO | Chief Executive Officer | - | 2026-05-31 |
Atul Ranchal
PSD | President | 57 | 2023-08-22 |
D. S. Maity
CTO | Chief Tech/Sci/R&D Officer | 62 | 2023-08-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2010-09-09 | |
Lalit Mahajan
BRD | Director/Board Member | 60 | 2011-09-12 |
| Director/Board Member | 53 | 2022-11-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.27% | -9.20% | - | - | 21.41M | ||
| +2.67% | +3.62% | +16.13% | +85.52% | 47.31B | ||
| -0.81% | -4.53% | +65.57% | +113.67% | 36.04B | ||
| +0.66% | -1.01% | -3.38% | +41.76% | 12.08B | ||
| +0.96% | +5.38% | +18.45% | +99.28% | 11.96B | ||
| +0.57% | +1.95% | +34.36% | +123.93% | 9.05B | ||
| +0.50% | -0.33% | +17.76% | +44.55% | 6.92B | ||
| -1.61% | +1.96% | +54.90% | -2.70% | 7.19B | ||
| +1.96% | +3.24% | +24.65% | +241.55% | 6.55B | ||
| -7.00% | +5.26% | -20.00% | +10.09% | 5.9B | ||
| Average | -0.34% | +1.69% | +23.16% | +84.18% | 15.89B | |
| Weighted average by Cap. | +0.60% | +2.11% | +29.22% | +90.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 795M 8.3M 7.28M 6.72M 6.21M 11.77M 12.01M 80.81M 31.4M 389M 31.17M 30.49M 1.35B | 826M 8.62M 7.56M 6.98M 6.45M 12.23M 12.47M 83.93M 32.61M 404M 32.38M 31.67M 1.4B |
| Net income | -196M -2.05M -1.79M -1.66M -1.53M -2.9M -2.96M -19.92M -7.74M -95.88M -7.68M -7.52M -333M | -99.67M -1.04M -913K -843K -779K -1.48M -1.51M -10.13M -3.94M -48.77M -3.91M -3.82M -169M |
| Net Debt | 55.16M 576K 505K 467K 431K 817K 833K 5.61M 2.18M 27M 2.16M 2.12M 93.71M | 75.39M 787K 691K 638K 589K 1.12M 1.14M 7.66M 2.98M 36.9M 2.96M 2.89M 128M |
Employees
323
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | ₹69.01 | -1.27% | 4,123 |
| 26-07-08 | ₹69.90 | -4.44% | 1,338 |
| 26-07-07 | ₹73.15 | -4.99% | 623 |
| 26-07-06 | ₹76.99 | -0.93% | 2,879 |
| 26-07-03 | ₹77.71 | +2.25% | 5,578 |
- Stock Market
- Stocks
- BROOKS Stock
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
















